
Thomas
Fossard
Investor Relations
In Q1 2021, SCOR’s financial results have been impacted by the unique combination of known and modelled Covid-19 claims development and a series of large natural catastrophes, driven by a polar vortex causing Texas Winter Storm Uri.
Covid-19 claims are manageable, developing as expected and tracking closely in line with what was previously communicated1. In Q1 2021, Covid-19 impact stands on the Life side at EUR 162 million2, of which EUR 145 million comes from the U.S. mortality portfolio, and overall has been stable on the P&C side since December 31, 2020.
The SCOR group continues to grow and to absorb shocks. SCOR records a net income of EUR 45 million in Q1 2021 and delivers a very high solvency of 232%, which reflects all expected future Covid-19 impacts and is above the optimal solvency range of 185% to 220% defined in “Quantum Leap”.
***
Denis Kessler, Chairman & Chief Executive Officer of SCOR, comments: “More than a year into the Covid-19 crisis, with its deep human, economic and financial impact, SCOR once again demonstrates the strength of its business model and the relevance of its strategy. SCOR relies on its expertise in risk and epidemiological modelling capabilities to predict and monitor the Covid-19 development and to estimate its foreseeable impacts on the Group. As expected, SCOR’s Q1 2021 results are significantly impacted by Covid-19, in particular on the Life side. In addition, on the P&C side, SCOR had to face in Q1 2021 a series of natural catastrophes driven by a polar vortex causing Winter Storm Uri in Texas, a remote tail risk event in this region of the United States. The probability of a polar vortex and a pandemic occurring in the same quarter is extremely low but is nonetheless one of the extreme scenarios within our risk appetite. On the investment side, SCOR was able to successfully seize opportunities in the fixed income market on the back of a reflation dynamic to crystallize value. SCOR is profitable in Q1 2021, delivers a very high level of liquidity and records a solvency level above its optimal range. As demonstrated by the successful January and April renewals, SCOR is very well positioned to benefit from improvements in pricing and terms and conditions in particular on the P&C (re)insurance market which should continue.”
In EUR millions (at current exchange rates) |
Q1 2021 | Q1 2020 | Variation |
---|---|---|---|
Gross written premiums | 4,125 | 4,158 | -0.8% |
Group cost ratio | 4.5% | 4.7% | -0.2 pts |
Annualized ROE | 2.9% | 10.7% | -7.8 pts |
Net income* | 45 | 162 | -72.2% |
Shareholders’ equity | 6,277 | 6,268 | +0.1% |
* Consolidated net income, Group share.
1 Please refer to the FY 2020 results press release published on February 24, 2021
2 Net of reduced flu claims in the U.S., net of retrocession and before tax, including IBNR
3 Based on a 5-year rolling average of 5-year risk-free rates (45 bps in Q1 2021)